Pepticom is excited to be taking an active role in shaping the future of AI in healthcare — Congratulations to Dr. Sarah Benson-Konforty, MD for joining the Board of Directors and Executive Committee of the The Alliance for Artificial Intelligence in Healthcare (AAIH)
The AAIH is a coalition of technology developers, pharmaceutical companies, and research organizations who share our goal of leveraging #AI to advance the quality of healthcare, with a special focus on AI-guided pharmaceutical development.Our advisor, Sarah Benson-Konforty, will attend our first AAIH Annual Members Meeting this May 17-18th in San Francisco.
Dr. Immanuel Lerner, CEO and co-founder of Pepticom, will speak at the TIDES Asia conference between March 7-9. His lecture will be about The Potential and Current Application of Artificial Intelligence in Peptide Drug Discovery. The conference will take place in Kyoto, from March 7-9, and he will be available for meetings there as well […]
The Pepticom Ltd. team, Our CEO Immanuel Lerner and Sarah Benson-Konforty, MD are attending the conference. You can meet them at our booth at the Health Innovation Lounge, the on-site hub of the Israeli health, tech & innovation community, and is located at 447 Sutter Street – a 2 min walk from the Westin St. Francis Hotel.